Find an expert

Carmen is an NHMRC Emerging Leadership Fellow at the National Centre for Youth Substance Use Research. Her research seeks to understand why young people start using substances and develop strategies that advance public health.

Her work spans three key areas:

(1) Youth vaping and social media, where she examines trends and the influence of social media on youth vaping; (2) Cannabis and regulation, investigating industry marketing practices and compliance with regulatory guidelines; (3) International comparisons and equity - developing culturally appropriate prevention and harm reduction strategies to address substance use in diverse contexts;

Through her research, Carmen aims to generate evidence that informs policy, guides prevention and harm reduction efforts, and support healthier futures for young people. She has published over 100 peer-reviewed papers in addiction and mental health (Google Scholar: >10K citations, h-index = 43, 31% output in top 10% citation percentile).

Carmen holds qualifications in biostatistics, public health and epidemiology. She has experiences in teaching and mentoring students from diverse demographic and cultural background, and welcomes self-driven, curious students with interest in public health, psychology, epidemiology, or statistics to join her team.

Dr Ye Wheen Lim's research combines cell biology, developmental biology and bio-nanotechnology to understand how nanoparticles interact with and cross biological barriers in physiological environments. His current research focuses on nanoparticle trafficking, nano-bio interactions and trans-endothelial transport, using zebrafish genetic models, advanced microscopy and cellular assays to define the mechanisms governing nanoparticle transport across blood vessels and other tissue interfaces. His work integrates fundamental cell biology with in vivo models to inform the development and therapeutic delivery of nanomedicines. Dr Lim has expertise in caveolae and membrane biology, endocytosis, cell mechanics, zebrafish biology, advanced microscopy and nanoparticle transport. His research has contributed to understanding the cellular mechanisms underlying biological barriers, including the blood vasculature and blood-brain barrier, as well as the development of lipid-based nanoparticles.

Dr Kai Li Lim is the inaugural St Baker Fellow in E-Mobility at the UQ Dow Centre for Sustainable Engineering Innovation. Specialising in data science, engineering, and emerging technologies, Dr Lim focuses on real-time vehicle telematics, infrastructure management, and computer vision-based autonomous driving.

At UQ, Dr Lim's research centres on electric vehicle (EV) usage and charging patterns to inform adoption policies and strategies. His work includes examining trends for incentive design and assessing the environmental and economic impacts of EVs. Dr Lim's current focus is on charging reliability and addressing EV drivers' pain points. His research has been featured in academic, industry, and media publications, facilitating discussions with various stakeholders.

Dr Lim has published a range of articles, book chapters, and conference papers in reputable venues. He has delivered invited talks and appeared in media outlets such as ABC, Courier Mail, and The Conversation. Collaborating with various UQ schools, including Civil Engineering, Electrical Engineering and Computer Science (EECS), Economics, and Environment, Dr Lim has secured funding for projects on topics like carbon emissions offset after EV uptake and evaluating price incentives for EV charging using real-time data.

In addition to his work at UQ, Dr Lim collaborates closely with the UC Davis Electric Vehicle Research Center, where he recently completed a six-month visiting fellowship on EV charging. He engages in speaking events and networking opportunities centred on sustainability and transportation innovation, delivering keynote speeches at conferences and industry roundtables.

Dr Lim holds a BEng (Hons) degree in electronic and computer engineering from the University of Nottingham, an MSc degree in computer science from Lancaster University, and a PhD degree from The University of Western Australia, supported by the Australian Government under the Research Training Programme.

Junxian Lim is an accomplished molecular biologist at the Institute for Molecular Bioscience. With a strong background in cell biology, protein biochemistry, and pharmacology, he has established himself in the field. Collaborating with researchers at universities, institutions, as well as international industry partners like AstraZeneca and Sosei Heptares, he has contributed significantly to advancing scientific knowledge.

Throughout his doctoral studies, Junxian authored seven ground-breaking studies focused on the development of novel bioactive inhibitors targeting immune cells and inflammatory diseases. These contributions have paved the way for innovative approaches to drug development. Utilizing his expertise, he has successfully developed and characterized a diverse range of protein and cellular assays that enable in-depth investigations into immunity and inflammation. His research findings have been published in prestigious scientific journals, including Nature Communications, Cell Reports, Journal of the American Chemical Society, Diabetes, Journal of Medicinal Chemistry, and the British Journal of Pharmacology. His work has been highly cited, reflecting its impact and significance within the scientific community.

Recognized for his outstanding mentoring abilities, Junxian has supervised or co-supervised the research of two completed PhD students, six completed MPhil students, and three completed Honours students. The success of his former students is a testament to his dedication and guidance. They continue to excel and actively contribute to research endeavours around the world, spanning countries such as Australia, Singapore, Korea, India, Japan, and China.

Beyond his research and mentoring achievements, Junxian actively participates in the scientific community. He serves on the editorial boards of esteemed journals like Journal of Translational Medicine, Frontiers in Molecular Biosciences and Biology. This involvement allows him to stay at the forefront of scientific advancements and contribute to the dissemination of knowledge within his field.

Dr Malcolm Lim is an experienced Cancer Biologist and His research interest spans cancer biology, biomarker discovery and theranostic nanomedicine.

He received his PhD from the University of Queensland (UQ) in 2022. His research, conducted in the labs of Professors Sunil Lakhani and Kristofer Thurecht, involved evaluating the efficacy of using nanomedicine for precision delivery of chemo- or radiotherapeutics against biomarkers in brain metastases. For this work, he developed a clinically-relevant brain metastasis mouse model. His research was recognised with the UQ Dean’s Award for Outstanding Thesis 2022. (DOIs: 10.1021/acs.molpharmaceut.3c00558, 10.3791/64216)

Currently, Malcolm serves as a Postdoctoral Research Fellow at the ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) and the Thurecht’s Lab at UQ-Centre for Advanced Imaging (CAI) in Australian Institute for Bioengineering and Nanotechnology (AIBN), where he will apply his multidisciplinary expertise to explore radiobiology and radiation-induced biological responses and to advance targeted pharmaceuticals for challenging cancers.

Prior to joining AMTAR, Malcolm served as a Postdoctoral Researcher where he investigated the molecular mechanisms underlying Early Breast Cancers at the Molecular Breast Pathology Lab, UQ-Centre for Clinical Research, under the mentorship of Professors Sunil Lakhani and Peter Simpson. Before his academic career, Malcolm had five years of experience as a histologist, which provided him with a broad skillset in the field.

Dr Malcolm’s research is well-documented in numerous publications in biomedical research journals despite his career stage, reflecting his passion to advancing cancer research.

My research focuses on mineral processing technologies, namely, grinding and flotation processes, with especial interest in understanding the complex interplay between ore mineralogy, mineral surface properties and process behaviour. I specialise in the application of advanced mineral surface characterisation techniques such as Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS) in mineral processing studies (e.g., grinding, flotation) to identify the key chemistry drivers of process behaviour. This knowledge is vital to understand the underlying mechanisms and devise solutions to improve process efficiency. I look to further develop advanced tools by integrating critical techniques such as ToF-SIMS, X-ray Photoelectron Spectroscopy, X-ray Tomography, Mineral Liberation Analysis and X-ray Fluorescence towards more comprehensive and faster mineral characterisation.

I am also interested in developing novel, highly selective reagents for mineral flotation to enable the processing of ores more efficiently, safely and environmentally friendly compared to the traditional reagents (of particular interest the use of biochemistries) and to develop new tools for the characterisation of process water chemistry.

My research covers both the fundamental aspects underlying mineral processes (e.g., particle-bubble interactions) as well as applications in the minerals industry through close collaborations with the industry. I am Chief Investigator in the ARC Centre of Excellence for Enabling Eco-Efficient Beneficiation of Minerals (https://coeminerals.org.au/) aiming to achieve a step-change in mineral processing by increasing energy and water efficiency and reducing metal loss during processing.

Shirina is a Lecturer in Finance at the UQ Business School. She completed her PhD in Finance at The University of Queensland, where her doctoral dissertation, "Three Essays on Irrational Managerial Characteristics", examined how different CEO traits influence corporate behaviour and decision-making.

After completing her doctorate, Shirina first joined UQ as a Teaching Associate before transitioning into her current role as Lecturer. Her research interests lie in CEO characteristics, corporate political activities, and corporate governance policies.

Dr Rijia Lin received his PhD in Chemical Engineering from the University of Queensland in 2016. In 2022, he was awarded the ARC DECRA Fellow. His main research interests include metal-organic frameworks, membrane gas separation, design and engineering of new porous glass materials.

Yifei Lin is a researcher at The University of Queensland’s Sustainable Minerals Institute, working in power systems modelling, geospatial analysis and risk management. Yifei combines engineering, information technology and network analysis to understand complex systems and support informed decisions about risk, reliability and resilience. Current work focuses on developing detailed models of electricity distribution networks at state scale using open tools and dtasets. This research brings together engineering modelling and geographic data to represent how electricity networks are structured and support their simulation and analysis. With a multidisciplinary background in civil engineering and information technology, Yifei’s experience spans plant reliability, risk assessment and software development for risk assessments, electricity modelling, and underground mining hazard assessments.

Key areas: Power systems modelling; geospatial analysis; risk management; graph theory; network analysis

I am a Clinician-Researcher in Haematology passionate about research discovery to better understand blood cancers and clinical translation to improve patient outcomes. I am an active clinical Haematologist (FRACP), Haematopathologist (FRCPA) and post-doctoral researcher (University of Queensland (UQ) and QIMR Berghofer Medical Research Institute). Following specialist qualifications, I embarked on a translational science PhD in Leukaemia biology at the University of Queensland (UQ) (conferred 2019). To translate that knowledge clinically, I undertook an additional qualification in diagnostic molecular haematology and commenced clinically-focussed research into frailty and its interaction with leukaemia biology to determine prognosis and treatment response. Within my research program in frailty, I provide direct supervision to medical and nursing early career researchers, fostering development of research capacity.

Dylan Lino researches in constitutional law and colonialism, especially in their historical and theoretical contexts. Much of his research has focused on the rights and status of Aboriginal and Torres Strait Islander peoples within Australia's settler constitutional order. He has also written on the imperial entanglements of British constitutional thought, focusing on the work of Victorian jurist AV Dicey. He holds a Bachelor of Laws (Honours) and a Bachelor of Arts from UNSW, a Master of Laws from Harvard University and a PhD from the University of Melbourne.

Dylan's research can be downloaded from SSRN. He is also on Twitter at @Dylan_Lino.